Investing Profile
Chris Garabedian
InvestorVC
CEO, Xontogeny and Portfolio Manager, PXV Fund
perceptivelife.com/team/Boston, Massachusetts
Your Intro Paths to Chris Garabedian
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Chris Garabedian on
cbCurrent Investing Position
Perceptive Advisors Investor
Investment Range
$100K - $10.0M
Sweet Spot
$1M
Investments On Record
21
Chris Garabedian is on these Sector & Stage Rankings
Chris Garabedian's Investments On Record (15)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Zucara Therapeutics | Series BNov 2024$20M Series AMar 2020$21M  | $41M |
Marea Therapeutics | Series BJun 2024$190M | $260M |
CereVasc | Series BMay 2024$70M Series AJun 2020$44M | $110M |
Delve Bio | Series AJun 2023$35M | $35M |
Peroxitech Therapeutics | Series ADec 2022$25M SeedMay 2021 | $25M |
Tellus Therapeutics | Series ADec 2022$35M SeedMay 2021$2M | $37M |
PolyCore Therapeutics | SeedApr 2022 | $500K |
VivoSense | Series AMar 2022$25M | $25M |
Investors who invest with Chris Garabedian
Founders who looked at Chris Garabedian's profile also looked at these Scouts & Angels